Panellists from left to right: Dr. Nicola Ranger, Professor Andrea Chiavari, David Barrett, and Professor Banu Demir Pakel at Oxford WERD event
From Fossil Fuels to Green Futures: Oxford and EBC Financial Group on What’s Holding Us Back
December 05, 2024 03:00 ET | EBC Financial Group
EBC and University of Oxford’s WERD Series panel explores global economic growth and climate resilience, spotlighting the role of policies and finance.
Banner for the What Economists Really Do event, featuring discussions on economic growth and climate resilience, sponsored by EBC Financial Group.
EBC Financial Group and the University of Oxford’s Department of Economics Announce WERD Episode on Macroeconomics and Climate
October 23, 2024 07:20 ET | EBC Financial Group
EBC and University of Oxford explore macroeconomic policies for climate resilience and sustainable growth in the WERD 2024-25 webinar series.
Oxford Alumni Pakistan forum on solving Pakistan's Permacrisis
OXFORD ALUMNI PAKISTAN Opposes the Use of Oxford’s Name for Political Gains
October 15, 2024 10:35 ET | Oxford Alumni Pakistan
Lahore, Pakistan, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Following the “National Dialogue on Pakistan’s Permacrisis” event held yesterday at the Governor House Lahore, Oxford Alumni Pakistan announced...
Imran Khan ineligible says King's Counsel Hugh Southey
Beltway Grid analyzes Imran Khan’s candidature for Oxford Chancellor
October 15, 2024 10:12 ET | Beltway Grid
London, United Kingdom, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Renowned policy advocacy group Beltway Grid has analyzed the recent Legal Opinion by the prestigious King’s Counsel Hugh Southey of the...
OH_RDC_Full_Colour_Logo_RGB.jpg
Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council
October 15, 2024 02:00 ET | Oxford-Harrington Rare Disease Centre
Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years OXFORD, UK and CLEVELAND,...
OMass logo.png
OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024
August 05, 2024 09:08 ET | OMass Therapeutics
PRESS RELEASE OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024 Oxford, United Kingdom – 5th August 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology...
Vela Partners AI Agent Comparison
New AI agent for venture capital: 100x cheaper, 5x faster and on-par quality with humans
June 05, 2024 08:00 ET | Vela Partners
Vela Partners & The University of Oxford publish research on a new LLM and AI agent that make investment decisions 100x cheaper and 5x faster than humans.
OrganOx.jpg
Appointment of Stephen M. Deitsch as new Chief Financial Officer
April 04, 2024 11:43 ET | ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
LA_CCA Abbreviated.png
LA&CCA Announces Collaborative Initiative with The University of Oxford for Scholarship Opportunity for Online Executive Diploma in Strategy & Innovation
January 25, 2024 20:00 ET | LA&CCA
LA&CCA offers Oxford scholarship for executives in strategy and innovation—apply by Feb 2.
OXB.jpg
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing
January 23, 2024 07:00 ET | Oxford BioMedica plc
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing Oxford, UK – 23 January 2024: On Wednesday 7 February, Oxford Biomedica, a quality and...